BRIEF-Eton Pharmaceuticals Announces Acquisition Of Pku Golike® For Phenylketonuria

Dow Jones Industrial Average DJI	0.00	0.00%
S&P 500 index SPX	0.00	0.00%
NASDAQ IXIC	0.00	0.00%
Eton Pharmaceuticals, Inc. ETON	0.00	0.00%

March 22 (Reuters) - Eton Pharmaceuticals Inc ETON.O:

ETON PHARMACEUTICALS ANNOUNCES ACQUISITION OF PKU GOLIKE® FOR PHENYLKETONURIA
ETON PHARMACEUTICALS ANNOUNCES ACQUISITION OF PKU GOLIKE® FOR PHENYLKETONURIA
TRANSACTION IS EXPECTED TO BE ACCRETIVE TO 2024 EARNINGS
TRANSACTION IS EXPECTED TO BE ACCRETIVE TO 2024 EARNINGS
ESTIMATED PEAK SALES OF MORE THAN $10 MILLION ANNUALLY
HAS ALSO BEEN GRANTED A RIGHT OF FIRST NEGOTIATION FOR RELIEF'S RLF-OD032 DEVELOPMENT CANDIDATE
ETON ALSO RECEIVED U.S. RIGHTS TO RELIEF'S GOLIKE MEDICAL FORMULAS LINE EXTENSIONS UNDER DEVELOPMENT

Source text for Eikon: ID:nGNX6F58h8

Further company coverage: ETON.O

((Reuters.Briefs@thomsonreuters.com;))

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.